CCT3 and colorectal adenocarcinoma: Similarly, as shown in Figure 5C,D, colorectal adenocarcinoma patients with rectal tumors (50 for DFS and 62 for OS) and lower levels of circ-CCT3 had significantly higher survival probabilities with regard to both DFS (p = 0.014) and OS (p = 0.038).